Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  
Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Understanding-COVID-19_pagePreview
5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials
By Natasa Spasic
On July 29, 2019

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Personal data privacy has taken another evolutionary step with the release of the Regulation (EU) 2016/679 of the European...


(5 minute read)

Tags: GDPR

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
GDPR_Checklist-cover